CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $399,000 | -67.7% | 68,516 | -66.9% | 0.03% | -69.3% |
| Q2 2022 | $1,236,000 | +222.7% | 206,954 | +152.6% | 0.10% | +215.6% |
| Q1 2022 | $383,000 | +175.5% | 81,941 | +47.5% | 0.03% | +52.4% |
| Q2 2021 | $139,000 | -21.0% | 55,555 | -8.2% | 0.02% | -46.2% |
| Q1 2021 | $176,000 | +402.9% | 60,548 | +456.4% | 0.04% | +254.5% |
| Q4 2020 | $35,000 | – | 10,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |